Epilepsy in Older Adults: Symptoms, Diagnosis, and Treatment
This paper examines epilepsy as it affects older adults, a population group in which the condition is three times more prevalent than in children. Drawing on peer-reviewed research and CDC data, the paper outlines the three major etiological classifications of epilepsy, explains why symptoms in older adults differ from those in younger populations, and discusses the compounding diagnostic challenges these differences create. It further addresses pharmacological treatment concerns unique to elderly patients — including adverse drug effects, altered pharmacokinetics, and polytherapy risks — and considers how conditions such as COVID-19 have added pressure to an already complex care landscape. The paper concludes by underscoring the importance of informed home care and mindful strategies alongside clinical intervention.
- Introduction: Personal connection and overview of epilepsy prevalence
- Classifications and Causes of Epilepsy in Older Adults: Three etiological types and new-onset causes
- Diagnostic Challenges in the Elderly Population: Why symptoms differ and diagnosis is harder
- Treatment Considerations and Pharmacological Challenges: EEG, drug interactions, and aging pharmacokinetics
- Conclusion: Call for awareness and holistic elder care
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Integrates multiple peer-reviewed sources (CDC, Lee, Liu et al., Kim et al., Seo et al.) to build a cumulative, evidence-based argument rather than relying on a single authority.
- Grounds the topic in a personal narrative — the author's experience with a grandmother who had epilepsy — which establishes relevance and emotional context before moving into clinical detail.
- Maintains a clear progression from epidemiology, to classification, to diagnosis, to treatment, giving the paper a logical and readable structure.
Key academic technique demonstrated
The paper demonstrates effective synthesis of sources: rather than summarizing each source in isolation, the author weaves findings from Liu et al., Lee, Kim et al., and Seo et al. together to build a coherent argument about the layered challenges of treating epilepsy in elderly patients. This synthesis technique is especially evident in the treatment section, where pharmacokinetic concerns, medication history, and EEG monitoring are connected into a single discussion.
Structure breakdown
The paper opens with a compelling statistic from the CDC followed by a personal anecdote, then moves through etiology and classification, diagnostic difficulties, treatment challenges, and a conclusion that calls for broader public awareness. This five-part structure — hook, background, complication, response, call to action — is a strong model for short persuasive academic papers.
Introduction
The Centers for Disease Control and Prevention (CDC) (2021) stated that more than 1 million older adults in the United States have epilepsy — a disease primarily known as a seizure-inducing disorder. Understanding why this statistic matters requires a brief personal context.
I was closely connected to my grandmother, who suffered from epilepsy. She lived with us, and I witnessed her difficulties firsthand, which affected me psychologically. I remained disturbed for quite some time after her passing.
Epilepsy presents different symptoms in young adults compared to older generations. Lee (2019) asserted that this may be due to varying body conditions and the non-specific characteristics of the disease, which affect every individual differently. These variations make diagnosis difficult even for specialists, leading to treatment procedures that must be highly individualized. The incidence of epilepsy is notably higher in older adults, which requires deeper exploration of its signs, causes, and emerging treatments centered on controlling epileptic seizures.
Classifications and Causes of Epilepsy in Older Adults
Liu et al. (2016) cited a finding by the International League Against Epilepsy from 2010 identifying three main classifications of epilepsy: genetic, structural or metabolic, and unidentified origin. All three causes may apply to older adults experiencing seizures. More than 50% of older adults have been found to have one of these etiological causes.
However, with recent global changes in disease patterns driven by environmental, climatic, and social lifestyle changes, new onset symptoms have emerged that place more than 30% of the elderly population at risk for cerebrovascular illness (Liu et al., 2016). The most common related symptoms in this population segment include nerve cell degeneration, stroke lesion, gliosis surrounding the lesion, and glial scar formation (Liu et al., 2016).
References
Centers for Disease Control and Prevention. (2021, September 13). Epilepsy and seizures in older adults.
Kim, T., Nguyen, P., Pham, N., Bui, N., Truong, H., Ha, S., & Vu, T. (2020). Epileptic seizure detection and experimental treatment: A review. Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.00701
Lee, S. K. (2019). Epilepsy in the elderly: Treatment and consideration of comorbid diseases. Journal of Epilepsy Research, 9(1), 27–35. https://doi.org/10.14581/jer.19003
Liu, S., Yu, W., & Lü, Y. (2016). The causes of new-onset epilepsy and seizures in the elderly. Neuropsychiatric Disease and Treatment, 12, 1425–1434. https://doi.org/10.2147/NDT.S107905
Seo, J. G., Cho, Y. W., Kim, K. T., Kim, D. W., Yang, K. I., Lee, S. T., Byun, J. I., No, Y. J., Kang, K. W., Kim, D., & Drug Committee of Korean Epilepsy Society. (2020). Pharmacological treatment of epilepsy in elderly patients. Journal of Clinical Neurology (Seoul, Korea), 16(4), 556–561. https://doi.org/10.3988/jcn.2020.16.4.556
Create your account
Always verify citation format against your institution’s current style guide requirements.